Xvivo Perfusion AB (publ) (XVIPF)
OTCMKTS
· Delayed Price · Currency is USD
32.90
0.00 (0.00%)
May 6, 2025, 4:00 PM EDT
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of $989.06 million as of May 7, 2025. Its market cap has increased by 6.86% in one year.
Market Cap
989.06M
Enterprise Value
959.23M
Revenue
85.18M
Ranking
n/a
PE Ratio
72.47
Stock Price
$32.90
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 56.07M to 989.06M, an increase of 1,663.96%. That is a compound annual growth rate of 25.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Tian'an Technology Group | 546.22M |
| Glass House Brands | 529.49M |
| Elite Pharmaceuticals | 452.95M |
| Northwest Biotherapeutics | 429.16M |
| CytoDyn | 401.57M |